Advertisement Pharmachem launches new diabetes management product - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pharmachem launches new diabetes management product

Pharmachem Laboratories has launched a diabetes management product, Prenulin, which combines a specific form of L-arabinose with chromium.

The ingredients have shown to lower both circulating glucose and insulin levels after consumption of a 70-gram sucrose challenge, compared to placebo, in two separate human studies.

The American Heart Association recommends no more than only nine teaspoons per day as the upmost limit of daily sugar consumption.

Pharmachem Laboratories new product development senior director Mitch Skop was quoted by newhope360 as saying that the excessive circulating sugars in the body is responsible for dramatic health issues and attendant health care costs.

"The beauty of Prenulin is that when sugar is consumed, the resulting blood sugar levels have been shown not to spike as they would without the ingredient," Skop added.

"Prenulin may be a welcome tool in consumers’ lifestyle modifications for more effective and long-lasting weight and sugar management."